CD8A and hepatocellular carcinoma: ,46,47 The prediction of patient response to cancer immunotherapy can be made by attractive biomarkers provided by these T-cell cluster marked genes, such as Layilin, which is found in depleted CD8+ T cells and hepatoma regulatory T cells, and these biomarkers may become novel targets for further research.